Gingicaine Fusion
Product Images NDC 10129-041

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Gingicaine Fusion (NDC 10129-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Active Ingredient (Active Ingredient)

This is a product with an active ingredient of Benzocaine at a concentration of 20% w/v. The purpose or use of the product is not specified in the given text.*

FDA Label Image

Allergy Alter (Allergy Alert)

This text contains a warning related to the use of a local anesthetic product. It advises users to avoid using the product if they have allergies to specific compounds and to seek medical attention if certain symptoms occur. It also provides instructions on what to do if the product is accidentally swallowed and recommends not exceeding the recommended dosage.*

FDA Label Image

Avoid Excessive Heat (Avoid Excessive Heat)

The text is a warning that states "Avoid Excessive heat Above 40°C (104°F)."*

FDA Label Image

Box (Box Package)

GINGICaine Fusion is a topical anesthetic gel that contains 20% benzocaine with 2% hemp extract. It offers quick onset (15-20 seconds) and up to 30 minutes of anesthesia, as well as immediate pain relief and a patient-friendly flavor. The product comes in a 0.81 oz (24 mL) size, containing 20 x 1.2 mL syringes and tips. This product is restricted by federal law for sale only by or on the order of a dentist, and should be stored away from excessive heat above 40°C (104°F). Gingi-Pak manufactures this product, and it is made in the USA.*

FDA Label Image

Federal Low (usa) Prohibits Dispensing Without Prescription. (Caution)

This text is a caution message advising to store a product within a temperature range from 15°C to 40°C.*

FDA Label Image

Consult A Doctor (Consult A Doctor)

This text is a set of health instructions advising readers to seek medical attention for certain symptoms. The text advises individuals with severe sore throat accompanied by fever, headache, rash, nausea, or vomiting to contact a doctor immediately. The text also advises individuals whose mouth sores do not heal after ten days, or those experiencing worsening pain, irritation or redness to seek medical attention.*

FDA Label Image

Should Not Be Used In Patients With History Of Hypersensitivity To Ester-type Local Anesthetics. (Contraindications)

This text provides important contraindications for using a specific product. It warns that it should not be used for teething or in infants and children younger than 2 years, as well as in patients with a history of hypersensitivity to ester-type local anesthetics.*

FDA Label Image

Description (Description)

GINGICaine Fusion is a topical local anesthetic containing 20% Benzocaine gel infused with 2% hemp extract. It is flavored with polyethylene glycol and sweetened with saccharin.*

FDA Label Image

Directions For Use (Directions)

This text provides directions for using a syringe with a micro needle tip to apply gel to targeted mucosal areas. It advises to dry the area first, verify flow, and apply a small amount to the tissue or pocket. It also suggests keeping the gel in place for at least one minute and disposing of the used needle tip and luer-lock cap after use.*

FDA Label Image

Dosage And Administration (Dosage)

This text provides instructions for the Dosage and Administration of a product called GINGICaine Fusion. The product is intended for use as a local anesthetic and should be applied only to the targeted mucosal area using sterile cotton or gauze. It is recommended to keep the gel in place for at least one minute and to not exceed the maximum dosage of 4 times daily. The product is suitable for adults and children two years or older, and care should be taken to avoid cross-contamination between patients.*

FDA Label Image

Inactive Ingredients (Inactive Ingredients)

This is a list of inactive ingredients found in a product. It includes polyethylene glycol (PEG) of two different molecular weights, sodium saccharin, hemp extract, flavoring, and FD&C Red #40, which is only present in the strawberry flavored product variant.*

FDA Label Image

Indications (Indications)

This text describes the uses of a product for anesthesia of oral mucous membranes. It is intended to minimize pain and discomfort during various dental procedures such as ulcers, needle punctures, deep scaling procedures, and the application of matrix bands. It also aids in the taking of dental impressions or intraoral radiographs in patients with an excessive gag reflex.*

FDA Label Image

Jar Box_vanilla (Jar Box Vanilla)

This text appears to be a product label for a topical gel named GINGICaine® Fusion. It comes in a 05.02 oz (14 gm) package and includes a warning for Methemoglobinemia - a rare blood disorder. Additionally, the product should not be used for teething or by infants and children under the age of two. There is also a mention of the manufacturer's website GINGIPAK.com. The process, however, seems to have added some random and unreadable characters making it hard to ensure the accuracy of the information.*

FDA Label Image

Jar Box_strawberry (Jar Box Strawberry)

This appears to be a description of a product called "GINGICaine Fusion" that contains 20% benzocaine and 2% hemp extract, and weighs 05 02 (14 gm). The text also provides warnings about possible side effects and instructions not to use the product on children younger than 2 years old. The product is designed for immediate pain relief and offers a long-lasting effect. However, parts of the text are not readable or are not in English, such as "uoisn4" and "eturiinena."*

FDA Label Image

Jar Label Stawberry

FDA Label Image

Jar Label Vanilla

This is a description of a product called "GINGICaine Fusion". It contains 20% Benzocaine with 2% Hemp Extract and comes in a 14 gm package. The product is a topical gel that has been infused with vanilla flavor. The dimensions of the package are 130mm x 14mm.*

FDA Label Image

Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)

This text is a warning label and advises to keep a certain product out of reach of children.*

FDA Label Image

Overdose (Overdose)

This text provides important cautionary information regarding the ingestion of a product. It advises seeking medical attention in the event that more than the recommended dosage is accidentally swallowed and warns against exceeding the recommended dosage.*

FDA Label Image

Precautions (Precautions)

This text provides precautions for dentists regarding the use of local anesthetics. Dentists are advised to avoid application to severely traumatized or infected mucosal areas and to use caution when administering local anesthetics to patients with known drug sensitivities, especially those allergic to ester-type anesthetics. Dentists are also advised to avoid contact with local anesthetics to prevent possible sensitization.*

FDA Label Image

Purpose (Purpose)

The product described is an oral anesthetic used for the temporary relief of pain in certain areas of the mouth.*

FDA Label Image

Syringe Stawberry

GINGICaine® Fusion is a topical gel infused with strawberry flavor which is not intended for infection or after-use WAL. It is made in the USA and has the batch number 201485 105-155 and the product code NoC 1012004021. However, it is not clear what was meant by "sty mny K 05203".*

FDA Label Image

Syringe_vanilla (Syringe Vanilla)

GINGICaine Fusion is a vanilla-infused topical gel made in the USA that may provide relief for dental related pain. There is no indication of whether it contains lidocaine, so it is unclear if it is a numbing agent. The product code is 105-156.*

FDA Label Image

Temper Evident Statement (Temper Evident Sleeve)

This text is a cautionary statement that warns not to use a product if the temper-evident sleeve is broken. It does not provide information about what product it is referring to or any additional details.*

FDA Label Image

Uses (Uses)

This text describes the uses of a product that helps reduce pain and discomfort caused by various dental procedures, such as scaling and root planing, minor gum injury, canker sores, sore throat, and minor mouth or gum irritation caused by dentures or orthodontic appliances. It also mentions that the product can aid in reducing discomfort during the healing process of mucous membranes.*

FDA Label Image

Warnings

This text provides warnings and precautions related to the use of a product that may cause a serious condition called methemoglobinemia, which reduces the amount of oxygen carried in blood. Symptoms of this condition and other side effects are listed, including pale, gray or blue skin, headache, rapid heart rate, shortness of breath, dizziness, lightheadedness, fatigue, and lack of energy. The product is intended for external use only and should not be used in children under 2 years of age.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.